Chronic low back pain. Low back pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Personal and conscious consent of the individual to participate in the research project Chronic mechanical low back pain without any specific pathology such as inflammation of the nerve root, spinal stenosis, spondylolysis, spondylolisthesis, vertebral fracture A history of more than three months of pain Confirmation of chronic low back pain and clinical examination by a specialist to rule out any pathology Age range between 30 and 70 years
Exclusion criteria
Exclusion criteria: Pregnancy or lactation Surgical history due to low back pain Non-mechanical back pain (wakes the patient up at night or causes pain and dryness in the morning) History of trauma, especially in the elderly Fever, sweating and weight loss without justification in recent months Long-term treatment with corticosteroeids Symptoms of cauda aquina syndrome include numbness and weakness in both legs, anal pain, perineal numbness or paresthesia, sphincter paralysis. Ankylosing spondylitis and inflammatory rheumatoid arthritis Existence of neuropathy or neurological problems during the examination Severe untreated scoliosis Infection at the site or spinal cord Acute radiculopathy (active herniated disc) Psychopathic disorders Uncontrolled diabetes or high blood pressure Participatory low back pain such as uterine or gastrointestinal involvement such as IBD Consumption of digoxin, warfarin, heparin Drug addiction, sedatives, alcohol, etc. Injecting anesthetics or corticosteroids for up to 4 weeks before starting treatment Fainting history after FASD or Hijamat(wet cupping)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity and disability score in Oswestry questionnaire. Timepoint: Before Intervention and After end of Intervention and 1 month after end of intervention. Method of measurement: Oswestry questionnaire.;Pain intensity score in VAS (Visual Analogue Scale) questionnaire. Timepoint: Before Intervention and After the first intervention session and After end of Intervention and 1 month after end of intervention. Method of measurement: VAS (Visual Analogue Scale) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences